ChiCTR1900020656
尚未开始
/
/
/
2019-01-12
/
/
結直腸癌
Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer
Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer
This study aims to develop a tailored risk communication intervention (TRCI) based on results of the systematic review on interventions to promote colonoscopy screening conducted by the principal investigator, and examine its effectiveness in promoting colonoscopy uptake among Chinese first-degree relatives (FDRs).
随机平行对照
卫生服务研究
Each family will be randomly assigned to TRSI group or control group with a 1:1 ratio using a sequence of block randomization number to assign cluster numbers equally to each group. A statistician will generates a random number sequence by computer software, a randomly mixed block size at 4-8 will b
Due to the nature of the intervention, blinding of participants and researchers is impossible. To avoid biased estimated of treatment effect, online survey will be conducted.?Participant will submit the web form back to the web server directly when the finish the assessment and the intervener are not able to influence the assessment.
N/A
/
105
/
2019-03-04
2019-10-31
/
(1) aged 40-75 years or 10 years before the age the relative was diagnosed; (2) individuals with 1 FDR with CRC at <60 years or with 2 or more FDRs with CRC at any age; (3) have not had a colonoscopy before; (4) with access to We-chat themselves or through close family members living in the same household; (5)able to read and speak Chinese. (6) living in Shenzhen；
登录查看(1) have history of cancer or inflammatory bowel disease; (2) recently participate in another study or previously participated in cancer risk counseling or study; (3) with doctor-diagnosed psychiatric illness.；
登录查看香港中文大學醫學院那打素護理學院
/
约印创投2025-01-16
求实药社2025-01-16
Genhouse2025-01-16
IPHASE2025-01-16
动脉网2025-01-16
动脉网-最新2025-01-16
药明康德2025-01-16
药明康德2025-01-16
再鼎医药2025-01-16
Rimonci2025-01-15
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
